findmyKOL

Barry Rutherford, MD

Basic profile

University of Missouri–Kansas City

ORCIDNone on fileNPI
RegionKansas City, MO · MidwestSpecialtyInterventional CardiologyFocusCardiology
ActivityNot yet indexedfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationSee ScholarshipOnline presenceNot yet checkedPaymentsNone reportedNIH fundingNot yet indexedWhy? →

Barry Rutherford is a Cardiology physician affiliated with University of Missouri–Kansas City. OpenAlex indexes 132 publications with 7,927 citations (h-index 46). By OpenAlex citation count, this profile ranks in the top 10% of Interventional Cardiology profiles in the findmyKOL directory.

Overview

Scholarship

indexed output and impact (OpenAlex)
132publications

Distinct works indexed by OpenAlex.

7,927citations

Total citations across indexed works.

46h-index

Hirsch index, productivity × impact (OpenAlex).

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    93.8%
    Beta blocker28%
    Metoprolol Succinate44%Carvedilol35%Metoprolol Tartrate21%
    Part D<11 patients
    Statin26.5%
    Atorvastatin Calcium79%Rosuvastatin Calcium11%Simvastatin10%
    Part D<11 patients

    + 7 more classes in this area

  • Blood & clotting

    3.2%
    P2Y12 inhibitor3.2%
    Clopidogrel100%
    Part D<11 patients
  • Metabolism & gastrointestinal

    3%
    Proton pump inhibitor3%
    Pantoprazole Sodium100%
    Part D<11 patients
Where care is delivered (Part B), 20220% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”